Anne Arundel Medical Center, a regional health system headquartered in Annapolis, Maryland, serves an area of more than one million people. Founded in 1902, AAMC includes a 380-bed not-for-profit hospital, a medical group, imaging services, a substance use treatment center, and health enterprises.

There are 385 beds in Anne Arundel Medical Center.

During the past decade, Anne Arundel Medical Center conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 38 clinical trials were completed, i.e. on average, 65.5% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 19 clinical trials were completed. i.e. 105.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Anne Arundel Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 20 trials, followed by "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "Anne Arundel Health System Research Institute" with 6 trials sponsored, "NRG Oncology" with 5 trials sponsored and "SWOG Cancer Research Network" with 5 trials sponsored. Other sponsors include 62 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Anne Arundel Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 34 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 92 different institutions and companies that were collaborators in the rest 75 trials.

According to Clinical.Site data, the most researched conditions in "Anne Arundel Medical Center" are "Breast Cancer" (14 trials), "Invasive Breast Carcinoma" (6 trials), "Recurrent Breast Carcinoma" (4 trials), "Stage II Breast Cancer" (4 trials) and "Stage IIIA Breast Cancer" (4 trials). Many other conditions were trialed in "Anne Arundel Medical Center" in a lesser frequency.

Most popular intervention types in "Anne Arundel Medical Center" are "Drug" (71 trials), "Other" (44 trials), "Radiation" (20 trials), "Biological" (19 trials) and "Procedure" (18 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (18 trials), "Quality-of-Life Assessment" (16 trials), "Placebo" (13 trials), "Paclitaxel" (10 trials) and "Docetaxel" (8 trials). Other intervention names were less common.

The vast majority of trials in "Anne Arundel Medical Center" are 85 trials for "All" genders, 21 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Anne Arundel Medical Center". undefined are not yet recruiting, 16 are recruiting, 38 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Anne Arundel Medical Center, 2 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Anne Arundel Medical Center, 3 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 65 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 13 trials that are defined as “Not Applicable".

Anne Arundel Medical Center has several departments that took part in Clinical trials: "DeCesaris Cancer Institute at Anne Arundel Medical Center" - 20 trials